BSX logo

Boston Scientific (BSX) Free cash flow

annual FCF:

$2.37B+$662.00M(+38.87%)
December 1, 2024

Summary

  • As of today (April 18, 2025), BSX annual free cash flow is $2.37 billion, with the most recent change of +$662.00 million (+38.87%) on December 1, 2024.
  • During the last 3 years, BSX annual FCF has risen by +$1.05 billion (+79.71%).
  • BSX annual FCF is now at all-time high.

Performance

BSX Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBSXcash flow metrics

quarterly FCF:

$1.16B+$465.00M(+66.62%)
December 1, 2024

Summary

  • As of today (April 18, 2025), BSX quarterly free cash flow is $1.16 billion, with the most recent change of +$465.00 million (+66.62%) on December 1, 2024.
  • Over the past year, BSX quarterly FCF has increased by +$465.00 million (+66.62%).
  • BSX quarterly FCF is now at all-time high.

Performance

BSX quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBSXcash flow metrics

TTM FCF:

$2.37B+$473.00M(+25.00%)
December 1, 2024

Summary

  • As of today (April 18, 2025), BSX TTM free cash flow is $2.37 billion, with the most recent change of +$473.00 million (+25.00%) on December 1, 2024.
  • Over the past year, BSX TTM FCF has increased by +$473.00 million (+25.00%).
  • BSX TTM FCF is now at all-time high.

Performance

BSX TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBSXcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

BSX Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+38.9%+66.6%+25.0%
3 y3 years+79.7%+157.3%+66.3%
5 y5 years+72.0%+157.3%+66.3%

BSX Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+158.8%at high+715.3%at high+351.3%
5 y5-yearat high+158.8%at high+715.3%at high+351.3%
alltimeall timeat high+983.1%at high+339.3%at high+396.0%

Boston Scientific Free cash flow History

DateAnnualQuarterlyTTM
Dec 2024
$2.37B(+38.9%)
$1.16B(+66.6%)
$2.37B(+25.0%)
Sep 2024
-
$698.00M(+19.3%)
$1.89B(+12.2%)
Jun 2024
-
$585.00M(-822.2%)
$1.69B(+8.6%)
Mar 2024
-
-$81.00M(-111.7%)
$1.55B(-8.8%)
Dec 2023
$1.70B(+86.3%)
$690.00M(+40.2%)
$1.70B(+5.4%)
Sep 2023
-
$492.00M(+8.8%)
$1.61B(+13.6%)
Jun 2023
-
$452.00M(+555.1%)
$1.42B(+21.3%)
Mar 2023
-
$69.00M(-88.5%)
$1.17B(+28.2%)
Dec 2022
$914.00M(-30.5%)
$602.00M(+101.3%)
$914.00M(+74.4%)
Sep 2022
-
$299.00M(+48.0%)
$524.00M(-10.1%)
Jun 2022
-
$202.00M(-206.9%)
$583.00M(-36.5%)
Mar 2022
-
-$189.00M(-189.2%)
$918.00M(-30.2%)
Dec 2021
$1.32B(+16.3%)
$212.00M(-40.8%)
$1.32B(-24.7%)
Sep 2021
-
$358.00M(-33.3%)
$1.75B(-7.2%)
Jun 2021
-
$537.00M(+156.9%)
$1.88B(+23.9%)
Mar 2021
-
$209.00M(-67.5%)
$1.52B(+34.3%)
Dec 2020
$1.13B(-17.7%)
$644.00M(+30.6%)
$1.13B(+0.1%)
Sep 2020
-
$493.00M(+183.3%)
$1.13B(+13.4%)
Jun 2020
-
$174.00M(-197.2%)
$997.00M(+6.4%)
Mar 2020
-
-$179.00M(-127.8%)
$937.00M(-31.9%)
Dec 2019
$1.38B(-872.5%)
$643.00M(+79.1%)
$1.38B(+121.4%)
Sep 2019
-
$359.00M(+214.9%)
$621.00M(-4.6%)
Jun 2019
-
$114.00M(-56.0%)
$651.00M(+1176.5%)
Mar 2019
-
$259.00M(-333.3%)
$51.00M(-128.7%)
Dec 2018
-$178.00M(-118.2%)
-$111.00M(-128.5%)
-$178.00M(-135.9%)
Sep 2018
-
$389.00M(-180.0%)
$496.00M(+8.5%)
Jun 2018
-
-$486.00M(-1720.0%)
$457.00M(-60.4%)
Mar 2018
-
$30.00M(-94.7%)
$1.15B(+18.1%)
Dec 2017
$976.00M(+44.8%)
$563.00M(+60.9%)
$976.00M(+23.5%)
Sep 2017
-
$350.00M(+66.7%)
$790.00M(+133.7%)
Jun 2017
-
$210.00M(-242.9%)
$338.00M(-28.2%)
Mar 2017
-
-$147.00M(-139.0%)
$471.00M(-30.1%)
Dec 2016
$674.00M(+278.7%)
$377.00M(-469.6%)
$674.00M(+83.2%)
Sep 2016
-
-$102.00M(-129.7%)
$368.00M(-54.5%)
Jun 2016
-
$343.00M(+512.5%)
$808.00M(+68.7%)
Mar 2016
-
$56.00M(-21.1%)
$479.00M(+169.1%)
Dec 2015
$178.00M(-81.9%)
$71.00M(-79.0%)
$178.00M(-59.8%)
Sep 2015
-
$338.00M(+2314.3%)
$443.00M(+12.2%)
Jun 2015
-
$14.00M(-105.7%)
$395.00M(-35.4%)
Mar 2015
-
-$245.00M(-172.9%)
$611.00M(-37.9%)
Dec 2014
$984.00M(+19.9%)
$336.00M(+15.9%)
$984.00M(+21.8%)
Sep 2014
-
$290.00M(+26.1%)
$808.00M(+14.4%)
Jun 2014
-
$230.00M(+79.7%)
$706.00M(-14.1%)
Mar 2014
-
$128.00M(-20.0%)
$822.00M(+0.1%)
Dec 2013
$821.00M(-20.4%)
$160.00M(-14.9%)
$821.00M(-16.6%)
Sep 2013
-
$188.00M(-45.7%)
$984.00M(-2.1%)
Jun 2013
-
$346.00M(+172.4%)
$1.00B(-0.8%)
Mar 2013
-
$127.00M(-60.7%)
$1.01B(-1.8%)
Dec 2012
$1.03B(+48.9%)
$323.00M(+54.5%)
$1.03B(+7.1%)
Sep 2012
-
$209.00M(-41.0%)
$964.00M(-8.4%)
Jun 2012
-
$354.00M(+142.5%)
$1.05B(+4.7%)
Mar 2012
-
$146.00M(-42.7%)
$1.00B(+45.0%)
Dec 2011
$693.00M(+1374.5%)
$255.00M(-14.1%)
$693.00M(-15.3%)
Sep 2011
-
$297.00M(-3.3%)
$818.00M(+158.0%)
Jun 2011
-
$307.00M(-284.9%)
$317.00M(+34.9%)
Mar 2011
-
-$166.00M(-143.7%)
$235.00M(+400.0%)
Dec 2010
$47.00M(-90.1%)
$380.00M(-286.3%)
$47.00M(-105.9%)
Sep 2010
-
-$204.00M(-190.7%)
-$799.00M(+295.5%)
Jun 2010
-
$225.00M(-163.6%)
-$202.00M(+146.3%)
Mar 2010
-
-$354.00M(-24.0%)
-$82.00M(-117.3%)
Dec 2009
$473.00M(-40.7%)
-$466.00M(-218.6%)
$473.00M(-39.6%)
Sep 2009
-
$393.00M(+13.9%)
$783.00M(-18.1%)
Jun 2009
-
$345.00M(+71.6%)
$956.00M(+21.0%)
Mar 2009
-
$201.00M(-228.8%)
$790.00M(-1.0%)
Dec 2008
$798.00M
-$156.00M(-127.6%)
$798.00M(-30.2%)
Sep 2008
-
$566.00M(+216.2%)
$1.14B(+15.2%)
DateAnnualQuarterlyTTM
Jun 2008
-
$179.00M(-14.4%)
$993.00M(+6.2%)
Mar 2008
-
$209.00M(+10.0%)
$935.00M(+63.7%)
Dec 2007
$571.00M(-62.0%)
$190.00M(-54.2%)
$571.00M(-7.6%)
Sep 2007
-
$415.00M(+243.0%)
$618.00M(+3.0%)
Jun 2007
-
$121.00M(-178.1%)
$600.00M(-27.6%)
Mar 2007
-
-$155.00M(-165.4%)
$829.00M(-44.9%)
Dec 2006
$1.50B(+167.6%)
$237.00M(-40.3%)
$1.50B(-10.8%)
Sep 2006
-
$397.00M(+13.4%)
$1.69B(+79.4%)
Jun 2006
-
$350.00M(-32.7%)
$940.00M(+27.0%)
Mar 2006
-
$520.00M(+24.1%)
$740.00M(+31.7%)
Dec 2005
$562.00M(-63.3%)
$419.00M(-220.1%)
$562.00M(-22.7%)
Sep 2005
-
-$349.00M(-332.7%)
$727.00M(-54.1%)
Jun 2005
-
$150.00M(-56.1%)
$1.58B(-17.2%)
Mar 2005
-
$342.00M(-41.4%)
$1.91B(+25.0%)
Dec 2004
$1.53B(+155.4%)
$584.00M(+15.2%)
$1.53B(+38.0%)
Sep 2004
-
$507.00M(+5.8%)
$1.11B(+46.3%)
Jun 2004
-
$479.00M(-1297.5%)
$758.00M(+56.3%)
Mar 2004
-
-$40.00M(-124.5%)
$485.00M(-19.0%)
Dec 2003
$599.00M(-4.0%)
$163.00M(+4.5%)
$599.00M(-1.3%)
Sep 2003
-
$156.00M(-24.3%)
$607.00M(-18.9%)
Jun 2003
-
$206.00M(+178.4%)
$748.00M(+10.3%)
Mar 2003
-
$74.00M(-56.7%)
$678.00M(+8.7%)
Dec 2002
$624.00M(+69.1%)
$171.00M(-42.4%)
$624.00M(+6.1%)
Sep 2002
-
$297.00M(+118.4%)
$588.00M(+55.6%)
Jun 2002
-
$136.00M(+580.0%)
$378.00M(+15.6%)
Mar 2002
-
$20.00M(-85.2%)
$327.00M(-11.4%)
Dec 2001
$369.00M(-44.3%)
$135.00M(+55.2%)
$369.00M(-4.4%)
Sep 2001
-
$87.00M(+2.4%)
$386.00M(-15.9%)
Jun 2001
-
$85.00M(+37.1%)
$459.00M(-22.7%)
Mar 2001
-
$62.00M(-59.2%)
$594.00M(-10.4%)
Dec 2000
$663.00M(-4.7%)
$152.00M(-5.0%)
$663.00M(+1.4%)
Sep 2000
-
$160.00M(-27.3%)
$654.00M(-14.6%)
Jun 2000
-
$220.00M(+67.9%)
$766.00M(+6.8%)
Mar 2000
-
$131.00M(-8.4%)
$717.00M(+3.0%)
Dec 1999
$696.00M(+489.8%)
$143.00M(-47.4%)
$696.00M(-1.0%)
Sep 1999
-
$272.00M(+59.1%)
$703.00M(+58.7%)
Jun 1999
-
$171.00M(+55.5%)
$443.00M(+82.3%)
Mar 1999
-
$110.00M(-26.7%)
$243.00M(+105.9%)
Dec 1998
$118.00M(-181.9%)
$150.00M(+1150.0%)
$118.00M(-245.5%)
Sep 1998
-
$12.00M(-141.4%)
-$81.10M(-44.6%)
Jun 1998
-
-$29.00M(+93.3%)
-$146.30M(-14.5%)
Mar 1998
-
-$15.00M(-69.5%)
-$171.20M(+18.9%)
Dec 1997
-$144.00M(-46.2%)
-$49.10M(-7.7%)
-$144.00M(-59.6%)
Sep 1997
-
-$53.20M(-1.3%)
-$356.00M(+24.7%)
Jun 1997
-
-$53.90M(-541.8%)
-$285.40M(+3.9%)
Mar 1997
-
$12.20M(-104.7%)
-$274.80M(+2.6%)
Dec 1996
-$267.80M(+92.5%)
-$261.10M(-1600.6%)
-$267.80M(+120.0%)
Sep 1996
-
$17.40M(-140.2%)
-$121.70M(-29.4%)
Jun 1996
-
-$43.30M(-325.5%)
-$172.50M(+22.4%)
Mar 1996
-
$19.20M(-116.7%)
-$140.90M(+1.3%)
Dec 1995
-$139.10M(-534.7%)
-$115.00M(+244.3%)
-$139.10M(+708.7%)
Sep 1995
-
-$33.40M(+185.5%)
-$17.20M(-186.0%)
Jun 1995
-
-$11.70M(-155.7%)
$20.00M(-42.7%)
Mar 1995
-
$21.00M(+204.3%)
$34.90M(+9.1%)
Dec 1994
$32.00M(+6.7%)
$6.90M(+81.6%)
$32.00M(-14.7%)
Sep 1994
-
$3.80M(+18.8%)
$37.50M(-24.8%)
Jun 1994
-
$3.20M(-82.3%)
$49.90M(+51.2%)
Mar 1994
-
$18.10M(+46.0%)
$33.00M(+10.0%)
Dec 1993
$30.00M(-6.5%)
$12.40M(-23.5%)
$30.00M(+15.4%)
Sep 1993
-
$16.20M(-218.2%)
$26.00M(+18.2%)
Jun 1993
-
-$13.70M(-190.7%)
$22.00M(-42.1%)
Mar 1993
-
$15.10M(+79.8%)
$38.00M(+18.4%)
Dec 1992
$32.10M(+43.9%)
$8.40M(-31.1%)
$32.10M(+35.4%)
Sep 1992
-
$12.20M(+430.4%)
$23.70M(+106.1%)
Jun 1992
-
$2.30M(-75.0%)
$11.50M(+25.0%)
Mar 1992
-
$9.20M
$9.20M
Dec 1991
$22.30M
-
-

FAQ

  • What is Boston Scientific annual free cash flow?
  • What is the all time high annual FCF for Boston Scientific?
  • What is Boston Scientific annual FCF year-on-year change?
  • What is Boston Scientific quarterly free cash flow?
  • What is the all time high quarterly FCF for Boston Scientific?
  • What is Boston Scientific quarterly FCF year-on-year change?
  • What is Boston Scientific TTM free cash flow?
  • What is the all time high TTM FCF for Boston Scientific?
  • What is Boston Scientific TTM FCF year-on-year change?

What is Boston Scientific annual free cash flow?

The current annual FCF of BSX is $2.37B

What is the all time high annual FCF for Boston Scientific?

Boston Scientific all-time high annual free cash flow is $2.37B

What is Boston Scientific annual FCF year-on-year change?

Over the past year, BSX annual free cash flow has changed by +$662.00M (+38.87%)

What is Boston Scientific quarterly free cash flow?

The current quarterly FCF of BSX is $1.16B

What is the all time high quarterly FCF for Boston Scientific?

Boston Scientific all-time high quarterly free cash flow is $1.16B

What is Boston Scientific quarterly FCF year-on-year change?

Over the past year, BSX quarterly free cash flow has changed by +$465.00M (+66.62%)

What is Boston Scientific TTM free cash flow?

The current TTM FCF of BSX is $2.37B

What is the all time high TTM FCF for Boston Scientific?

Boston Scientific all-time high TTM free cash flow is $2.37B

What is Boston Scientific TTM FCF year-on-year change?

Over the past year, BSX TTM free cash flow has changed by +$473.00M (+25.00%)
On this page